Detalhe da pesquisa
1.
Inductively Coupled Plasma Mass SpectrometryâA Valid Method for the Characterization of Metal Conjugates in View of the Development of Radiopharmaceuticals.
Mol Pharm
; 20(4): 2150-2158, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36826437
2.
Impact of the mouse model and molar amount of injected ligand on the tissue distribution profile of PSMA radioligands.
Eur J Nucl Med Mol Imaging
; 49(2): 470-480, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34402925
3.
Preclinical investigations using [177Lu]Lu-Ibu-DAB-PSMA toward its clinical translation for radioligand therapy of prostate cancer.
Eur J Nucl Med Mol Imaging
; 49(11): 3639-3650, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35635566
4.
Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms.
Eur J Nucl Med Mol Imaging
; 49(4): 1113-1126, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625828
5.
Design and Evaluation of Novel Albumin-Binding Folate Radioconjugates: Systematic Approach of Varying the Linker Entities.
Mol Pharm
; 19(3): 963-973, 2022 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35192367
6.
Preclinical Investigations to Explore the Difference between the Diastereomers [177Lu]Lu-SibuDAB and [177Lu]Lu-RibuDAB toward Prostate Cancer Therapy.
Mol Pharm
; 19(7): 2105-2114, 2022 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544699
7.
Occupational risk assessment of exposure to metals in chrome plating workers.
Drug Chem Toxicol
; 45(2): 560-567, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32106715
8.
Novel Synthetic Strategies Enable the Efficient Development of Folate Conjugates for Cancer Radiotheranostics.
Bioconjug Chem
; 32(8): 1617-1628, 2021 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34251183
9.
Promising potential of [177Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy-a preclinical study using a syngeneic breast cancer model.
Eur J Nucl Med Mol Imaging
; 48(4): 984-994, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33078260
10.
Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates-new perspectives for folate receptor-targeted radionuclide therapy.
Eur J Nucl Med Mol Imaging
; 48(4): 972-983, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33063250
11.
Biodistribution and dosimetry of a single dose of albumin-binding ligand [177Lu]Lu-PSMA-ALB-56 in patients with mCRPC.
Eur J Nucl Med Mol Imaging
; 48(3): 893-903, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32949253
12.
Combined Application of Albumin-Binding [177Lu]Lu-PSMA-ALB-56 and Fast-Cleared PSMA Inhibitors: Optimization of the Pharmacokinetics.
Mol Pharm
; 17(6): 2044-2053, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32383887
13.
Single Photon Emission Computed Tomography Tracer.
Recent Results Cancer Res
; 216: 227-282, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32594389
14.
Expanding the Scope of Pyclen-Picolinate Lanthanide Chelates to Potential Theranostic Applications.
Inorg Chem
; 59(16): 11736-11748, 2020 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32799456
15.
Albumin-Binding PSMA Radioligands: Impact of Minimal Structural Changes on the Tissue Distribution Profile.
Molecules
; 25(11)2020 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32486054
16.
Developments toward the Implementation of 44Sc Production at a Medical Cyclotron.
Molecules
; 25(20)2020 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33066650
17.
Targeted Radiotherapeutics from 'Bench-to-Bedside'.
Chimia (Aarau)
; 74(12): 939-945, 2020 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33357286
18.
Concentration-dependent effects of dutasteride on prostate-specific membrane antigen (PSMA) expression and uptake of 177 Lu-PSMA-617 in LNCaP cells.
Prostate
; 79(12): 1450-1456, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31233227
19.
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer.
Eur J Nucl Med Mol Imaging
; 46(9): 1919-1930, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31134301
20.
First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum.
Eur J Nucl Med Mol Imaging
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38448550